Jane Street’s Bionano Genomics BNGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-59
Closed -$21.5K 8651
2023
Q2
$21.5K Sell
59
-52
-47% -$23.5K ﹤0.01% 8354
2023
Q1
$73.8K Sell
111
-181
-62% -$161K ﹤0.01% 8343
2022
Q4
$256K Sell
292
-115
-28% -$145K ﹤0.01% 7285
2022
Q3
$446K Buy
407
+109
+37% +$144K ﹤0.01% 6889
2022
Q2
$247K Buy
298
+77
+35% +$79.2K ﹤0.01% 7895
2022
Q1
$342K Sell
221
-1,713
-89% -$2.31M ﹤0.01% 8184
2021
Q4
$3.47M Sell
1,934
-153
-7% -$409K ﹤0.01% 3445
2021
Q3
$6.89M Sell
2,087
-257
-11% -$899K ﹤0.01% 2291
2021
Q2
$10.3M Buy
2,344
+882
+60% +$3.48M ﹤0.01% 1668
2021
Q1
$7.09M Buy
+1,462
New +$8.24M ﹤0.01% 1941

Other funds holding BNGO

Jane Street's BNGO Position: Q2 2026 in Review

Jane Street opened a new position in Bionano Genomics (BNGO) in Q2 2026: 35,728 shares worth $40.4K. The stake represents ﹤0.01% of the portfolio and ranks #11012 among its holdings. This is a return to the name: Jane Street previously reported a position in BNGO as recently as Q4 2025.

Jane Street first reported a position in BNGO in Q4 2020 and has held it in 17 quarters since. The position peaked at $9.8M in Q1 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Jane Street held 35,728 shares of Bionano Genomics worth $40.4K as of Q2 2026.
  • Bionano Genomics was a new Jane Street position in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #11012 holding.
  • Jane Street first reported a position in Bionano Genomics in Q4 2020 and has held it in 17 quarters since.
  • Jane Street's Bionano Genomics position peaked at $9.8M in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.